State of Wisconsin Investment Board’s Adverum Biotechnologies ADVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,980
Closed -$1.18M 2062
2021
Q1
$1.18M Sell
11,980
-200
-2% -$24K ﹤0.01% 1324
2020
Q4
$1.32M Buy
12,180
+510
+4% +$63.1K ﹤0.01% 1267
2020
Q3
$1.2M Sell
11,670
-340
-3% -$50.9K ﹤0.01% 1252
2020
Q2
$2.51M Buy
12,010
+2,250
+23% +$398K 0.01% 1086
2020
Q1
$954K Buy
9,760
+1,800
+23% +$210K ﹤0.01% 1213
2019
Q4
$917K Hold
7,960
﹤0.01% 1264
2019
Q3
$434K Buy
7,960
+410
+5% +$46.2K ﹤0.01% 1372
2019
Q2
$898K Buy
7,550
+170
+2% +$14.1K ﹤0.01% 1171
2019
Q1
$387K Buy
7,380
+1,690
+30% +$68.3K ﹤0.01% 1398
2018
Q4
$179K Hold
5,690
﹤0.01% 1459
2018
Q3
$344K Buy
+5,690
New +$320K ﹤0.01% 1452

Other funds holding ADVM

State of Wisconsin Investment Board's ADVM Position: Q2 2021 in Review

State of Wisconsin Investment Board sold out of Adverum Biotechnologies (ADVM) in Q2 2021, closing a stake of 11,980 shares — an estimated $1.18M sold.

State of Wisconsin Investment Board first reported a position in ADVM in Q3 2018 and held it in 11 quarters. The position peaked at $2.51M in Q2 2020. 118 funds tracked by Wall St. Rank hold ADVM as of Q2 2021.

  • State of Wisconsin Investment Board reported no remaining Adverum Biotechnologies position as of Q2 2021 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 11,980 Adverum Biotechnologies shares in Q2 2021, an estimated $1.18M.
  • State of Wisconsin Investment Board first reported a position in Adverum Biotechnologies in Q3 2018 and held it in 11 quarters.
  • State of Wisconsin Investment Board's Adverum Biotechnologies position peaked at $2.51M in Q2 2020.
  • 118 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2021, filed 12 Aug 2021.